UBS Group’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8K | Buy |
1,938
+1,936
| +96,800% | +$19.8K | ﹤0.01% | 7141 |
|
|
2025
Q1 | $18 | Sell |
2
-296
| -99% | -$2.66K | ﹤0.01% | 8780 |
|
|
2024
Q4 | $4.85K | Buy |
+298
| New | +$4.85K | ﹤0.01% | 7476 |
|
|
2024
Q3 | – | Sell |
-44
| Closed | -$1.98K | – | 8226 |
|
|
2024
Q2 | $1.98K | Buy |
+44
| New | +$1.98K | ﹤0.01% | 7282 |
|
|
2023
Q2 | – | Sell |
-145
| Closed | -$10K | – | 7738 |
|
|
2023
Q1 | $10K | Buy |
145
+8
| +6% | +$554 | ﹤0.01% | 6518 |
|
|
2022
Q4 | $10.9K | Sell |
137
-67
| -33% | -$5.33K | ﹤0.01% | 7270 |
|
|
2022
Q3 | $12K | Buy |
204
+152
| +292% | +$8.94K | ﹤0.01% | 7034 |
|
|
2022
Q2 | $4K | Buy |
+52
| New | +$4K | ﹤0.01% | 7983 |
|